Daniel Caput

TL;DR: SR141716A is the first selective and orally active antagonist of the brain cannabinoid receptor and should prove to be a powerful tool for investigating the in vivo functions of the anandamide/cannabinoid system.

TL;DR: It is concluded that the hORL1 receptor is a new member of the opioid receptor family with a potential role in modulating a number of brain functions, including instinctive behaviours and emotions.

TL;DR: MCP-3 combines the properties of RANTES, a powerful chemoattractant, and MCP-1, a highly effective stimulus of mediator release, and thus has a particularly broad range of activities toward both human basophil and eosinophil leukocytes.

TL;DR: Cloning a CRF receptor complementary DNA by expression in COS‐7 cells of a cDNA library from the AtT20 mouse pituitary tumour cell line suggests a major role for this neuropeptide in the integration of the overall physiological and behavioral responses of an organism to stress.

TL;DR: Cloned cDNA encoding an IL-13 binding protein with two consensus patterns characteristic of the hematopoietic cytokine receptor family and a short cytoplasmic tail shows homology with the IL-5 receptor, and to a lesser extent, with the prolactin receptor.